Johnson & Johnson Invests €580 Million in Italian Manufacturing Operations Over Five Years

1. Investment Amount: Johnson & Johnson Innovative Medicine will invest €580 million in Italy over the next five years.
2. Capacity Upgrade: €125 million will be dedicated to upgrading the company's tablet manufacturing site at Latina, increasing production capacity by more than 25%.
3. Latina Site: The site produces over 4 billion tablets annually, with 97% of production exported globally.
4. Research and Development: J&J has invested nearly €50 million in R&D in Italy over the past five years, with a focus on clinical trials and collaborations with research centers.
5. Employment: The company employs around 1,370 people in Italy, with a 15% increase in employment over the last five years.
6. Industry Impact: The investment is expected to have a significant direct and indirect impact on the Italian economy, generating over 7,000 jobs.
7. Technological Advancements: The upgrade includes the implementation of an automated Flex Line platform and a new continuous manufacturing line to streamline production and reduce timelines.
8. Global Supply Chain: The Latina site is a key part of Johnson & Johnson's global supply chain network, serving patients worldwide.
9. Commitment to Innovation: The investment demonstrates J&J's commitment to innovation, sustainability, and research in Italy, fostering a strong clinical trials ecosystem and constructive dialogue with institutions.